690 related articles for article (PubMed ID: 12001633)
1. [Beta blockers reduce cardiac complications in patients undergoing surgery].
Hynynen M
Duodecim; 2000; 116(17):1805-7. PubMed ID: 12001633
[No Abstract] [Full Text] [Related]
2. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockers and risk of all-cause mortality in non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Repaci S; del Pinto M; Gentile G; Cavallini C; Reboldi G
Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):109-18. PubMed ID: 20200201
[TBL] [Abstract][Full Text] [Related]
4. Clinical inquiries. Which patients undergoing noncardiac surgery benefit from perioperative beta-blockers?
Haynes J; Kelsberg G; Jamieson B; Lo V
J Fam Pract; 2008 Feb; 57(2):121-3. PubMed ID: 18248734
[No Abstract] [Full Text] [Related]
5. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Schouten O; Poldermans D; Visser L; Kertai MD; Klein J; van Urk H; Simoons ML; van de Ven LL; Vermeulen M; Bax JJ; Lameris TW; Boersma E
Am Heart J; 2004 Dec; 148(6):1047-52. PubMed ID: 15632892
[No Abstract] [Full Text] [Related]
7. Acute peri-operative beta blockade in intermediate-risk patients.
Biccard BM; Sear JW; Foëx P
Anaesthesia; 2006 Oct; 61(10):924-31. PubMed ID: 16978304
[TBL] [Abstract][Full Text] [Related]
8. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review.
Auerbach AD; Goldman L
JAMA; 2002 Mar; 287(11):1435-44. PubMed ID: 11903031
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic beta-blocker use to prevent perioperative morbidity and mortality.
Finley AC; Elliott BM; Robison JJ; Brothers TE
J S C Med Assoc; 2004 Aug; 100(8):223-6. PubMed ID: 15490951
[TBL] [Abstract][Full Text] [Related]
10. [Beta-blocker therapy and risk reduction in non-cardiac surgery].
Passamonti E; Pirelli S
Ital Heart J Suppl; 2003 Feb; 4(2):96-101. PubMed ID: 12762258
[TBL] [Abstract][Full Text] [Related]
11. [The patient with cardiac disease].
Wetterslev J; Holmvang L
Ugeskr Laeger; 2006 Dec; 168(49):4305-9. PubMed ID: 17164059
[TBL] [Abstract][Full Text] [Related]
12. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
Kaafarani HM; Atluri PV; Thornby J; Itani KM
Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
[TBL] [Abstract][Full Text] [Related]
13. Use of beta-blockade to prevent death after noncardiac surgery.
Wallace A; Mangano DT
West J Med; 1997 Mar; 166(3):203-4. PubMed ID: 9143199
[No Abstract] [Full Text] [Related]
14. [Use of medicines to reduce the risk of postoperative cardiac death: too early for guidelines].
Kalkman CJ; van Klei WA
Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2600-2. PubMed ID: 19102433
[TBL] [Abstract][Full Text] [Related]
15. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A
Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213
[TBL] [Abstract][Full Text] [Related]
16. Can attenuation of the perioperative stress response prevent intermediate or long-term cardiovascular outcomes among patients undergoing noncardiac surgery?
Devereaux PJ
Anesthesiology; 2009 Aug; 111(2):223-6. PubMed ID: 19568160
[No Abstract] [Full Text] [Related]
17. [Perioperative risk reduction in vascular surgery via cardio-protective medication].
Feringa HH; Bax JJ; Poldermans D
Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2606-11. PubMed ID: 19102435
[TBL] [Abstract][Full Text] [Related]
18. [Perioperative beta-blockade for reduction of cardiovascular complications in non-cardiac surgery: advantages and disadvantages].
Koelemay MJ; Legemate DA
Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2603-5. PubMed ID: 19102434
[TBL] [Abstract][Full Text] [Related]
19. Pro: Beta-blockers are indicated for patients at risk for cardiac complications undergoing noncardiac surgery.
Schouten O; Bax JJ; Dunkelgrun M; Feringa HH; Poldermans D
Anesth Analg; 2007 Jan; 104(1):8-10. PubMed ID: 17179237
[No Abstract] [Full Text] [Related]
20. [Still uncertainty about the usefulness of perioperative beta-blockade. Conclusive studies concerning patients with cardiovascular risk factors not available].
Gannedahl P
Lakartidningen; 2006 Sep 13-19; 103(37):2638-40, 2643. PubMed ID: 17022183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
